Dual Targeting of Raf and VEGF Receptor 2 Reduces Growth and Metastasis of Pancreatic Cancer Through Direct Effects on Tumor Cells, Endothelial Cells, and Pericytes

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-08-0373
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

VEGF Receptor-2/Neuropilin1 Trans -Complex Formation Between Endothelial and Tumor Cells Is an Independent Predictor of Pancreatic Cancer Survival

Journal of Pathology
Forensic MedicinePathology
2018English

Benefits of Targeting Both Pericytes and Endothelial Cells in the Tumor Vasculature With Kinase Inhibitors

Journal of Clinical Investigation
Medicine
2003English

Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes

Frontiers in Immunology
AllergyImmunology
2020English

The ADMR Receptor Mediates the Effects of Adrenomedullin on Pancreatic Cancer Cells and on Cells of the Tumor Microenvironment

PLoS ONE
Multidisciplinary
2009English

Transthyretin Stimulates Tumor Growth Through Regulation of Tumor, Immune, and Endothelial Cells

Journal of Immunology
AllergyImmunology
2018English

Classification of Renal Cell Carcinoma Based on Expression of VEGF and VEGF Receptors in Both Tumor Cells and Endothelial Cells

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2008English

Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells

PLoS ONE
Multidisciplinary
2015English

Blockade of Epidermal Growth Factor Receptor Signaling on Tumor Cells and Tumor-Associated Endothelial Cells for Therapy of Human Carcinomas

American Journal of Pathology
Forensic MedicinePathology
2002English

Targeting Interleukin-11 Receptor- Impairs Human Endometrial Cancer Cell Proliferation and Invasion in Vitro and Reduces Tumor Growth and Metastasis in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy